Procaine IV Therapy for Mental Wellness:
A Regenerative Approach to Cognitive and Emotional Health
Mental wellness is increasingly understood not as a purely psychological phenomenon, but as a deeply biological one. Mood, cognition, memory, and emotional resilience all depend on the integrity of the nervous system, including the health of neurotransmitters, the degree of neurological inflammation, and the availability of key biochemical precursors.1
When these systems are compromised, the consequences extend far beyond how a person feels on a given day. They shape energy levels, decision-making capacity, relational health, and overall quality of life.At The Longevity Centers, we use a variety of regenerative therapies to address the root causes of mental and neurological decline, as opposed to merely managing symptoms. Among these, procaine IV therapy occupies a particularly compelling position, one grounded in decades of international clinical research and a sophisticated understanding of how a single compound can influence the nervous system at multiple levels.
What Is Procaine?
Procaine is a synthetic local anesthetic first developed in the early twentieth century for use in surgical procedures. (Note that procaine taken by mouth is distinct from the prescription version administered by injection.) While it remains used in certain medical settings for pain management, its broader therapeutic potential—particularly in intravenous application—has attracted significant attention from the longevity and integrative medicine communities since the mid-twentieth century. The foundational research on procaine as a systemic therapy was pioneered by Romanian physician Dr. Ana Aslan, who developed a formulation known as Gerovital H3. Her work, conducted over several decades at the National Institute of Gerontology and Geriatrics in Bucharest, identified procaine not merely as a local anesthetic but as a metabolically active compound with meaningful effects on the central nervous system, mood regulation, and cognitive function.2
How Procaine IV Therapy Works
When administered intravenously, procaine is metabolized into two primary compounds: para-aminobenzoic acid (PABA) and diethylaminoethanol (DEAE). Each of these metabolites plays a distinct and important role in neurological and systemic health.
PABA functions as a precursor to folic acid and supports cellular repair processes. It also exhibits antioxidant properties that help protect neural tissue from oxidative stress—a key driver of both cognitive decline and mood instability.DEAE is a structural relative of choline and serves as a precursor to acetylcholine (ACh), a neurotransmitter essential to memory, learning, and parasympathetic nervous system function. Elevated ACh activity is associated with improved attention, recall, and emotional regulation.3 Additionally, procaine acts as a mild, reversible inhibitor of monoamine oxidase (MAO), an enzyme responsible for the breakdown of key neurotransmitters, including serotonin, dopamine, and norepinephrine.
Why Choose LCOA
What Sets Longevity Centers of America Apart?
- Personalized protocols tailored to your unique health goals
- Physician-led team with advanced training in functional and longevity medicine
- In-depth testing and root-cause diagnostics
- Concierge-level care and long-term support
- Proven therapies backed by science
- A calm, comfortable, and discreet environment
Mental Wellness Applications
The mental wellness applications of procaine IV therapy are broad and intersect with several of the most common neurological and psychological concerns seen in aging and high-stress populations. Clinically, the therapy has been studied and applied in the following contexts:
- Depression and mood dysregulation: Through its MAO-inhibiting properties and support of serotonin and dopamine availability, procaine has been shown in clinical observations to improve depressive symptoms, emotional flatness, and motivational deficits—particularly in patients for whom conventional treatments have produced limited results.4
- Cognitive decline and memory impairment: By supporting ACh synthesis and reducing neuroinflammation, procaine IV therapy may slow the progression of age-related cognitive decline and support clarity, processing speed, and memory consolidation.5
- Anxiety and nervous system dysregulation: The parasympathetic support offered by DEAE and the stabilizing influence on neurotransmitter balance can produce a calming effect on an overactivated nervous system, addressing the biological substrate of chronic anxiety rather than merely suppressing its symptoms.
- Mental fatigue and brain fog: Patients dealing with chronic cognitive fatigue or poor concentration often report improvements in mental energy and clarity following a course of procaine IV therapy.
What to Expect from Treatment
At The Longevity Centers, procaine IV therapy is administered in a clinical setting under the guidance of experienced practitioners. The infusion process is typically well-tolerated, and most patients report few if any adverse effects during or following treatment.
A standard therapy session involves:
- An initial consultation and comprehensive assessment to determine candidacy and establish baseline neurological and metabolic health markers
- A series of infusions administered over several weeks, with frequency and duration tailored to the individual patient’s needs and goals
- Periodic reassessment to evaluate response and adjust the treatment protocol as indicated
- Integration with complementary therapies—such as NAD+ infusions, hormone optimization, or nutritional support—to maximize neurological benefit
The experience of procaine IV administration is generally described as relaxing. Some patients note a mild warmth or tingling sensation during infusion, which is a normal physiological response to the compound. Mental clarity and improved mood are often among the first effects reported, sometimes within the initial sessions of a treatment series.
Frequently Asked Questions
Is procaine IV therapy safe?
When administered by qualified medical professionals in an appropriate clinical setting, procaine IV therapy has a well-established safety profile supported by decades of use in integrative and longevity medicine. As with any IV therapy, a thorough medical evaluation is conducted prior to treatment to identify any contraindications and ensure the protocol is appropriate for each individual patient.
Who is a good candidate for procaine IV therapy?
Individuals experiencing symptoms of depression, anxiety, cognitive fatigue, brain fog, or age-related cognitive decline may benefit from procaine IV therapy. It is also well-suited for patients seeking proactive neurological support as part of a broader longevity or anti-aging protocol. A comprehensive intake assessment at The Longevity Centers will help determine whether this therapy is appropriate for your specific needs.
How does procaine IV therapy differ from antidepressant medications?
Unlike conventional antidepressants, which typically target a single neurotransmitter pathway (such as serotonin reuptake), procaine IV therapy works through multiple mechanisms simultaneously, supporting neurotransmitter availability, reducing neuroinflammation, promoting ACh synthesis, and protecting neural tissue from oxidative damage. This broader, systems-level approach aligns with a root-cause philosophy of care, rather than mere symptom suppression.
Can procaine IV therapy be used alongside conventional psychiatric medications?
This is an important clinical question that must be addressed on an individual basis. Because procaine has mild MAO-inhibiting properties, it is essential that your provider be informed of all current medications, particularly antidepressants and other psychiatric drugs, before beginning therapy. In many cases, thoughtful integration is possible, but it requires careful medical oversight.
How many sessions are typically needed to experience benefits for mental wellness?
The number of procain IV therapy sessions required varies depending on the patient’s health status, the severity of symptoms, and individual response to treatment. Some patients report noticeable improvements in mood and mental clarity within the first few infusions, while others require a more extended course of therapy to achieve optimal results. Your care team at The Longevity Centers will work with you to develop a personalized treatment plan.
References
- Sophie Ouabbou, Ying He, Keith Butler, and Ming Tsuang, “Inflammation in Mental Disorders: Is the Microbiota the Missing Link?” Neuroscience Bulletin, June 2020, https://pmc.ncbi.nlm.nih.gov/articles/PMC7475155/.
- Dan L. Dumitrascu, M.D., Marc A. Shampo, Ph.D., and Robert A. Kyle, M.D., “Ana Aslan—Founder of the First Institute of Geriatrics,” Stamp Vignette on Medical Science, Vol. 73, Iss. 10, October 1998, https://www.mayoclinicproceedings.org/article/S0025-6196(11)63390-9/fulltext.
- “Procaine,” National Center for Biotechnology Information, National Library of Medicine, retrieved on April 1, 2026, from: https://pubchem.ncbi.nlm.nih.gov/compound/Procaine#section=Drug-Drug-Interactions.
- Luana Vergueiro Ribeiro, Larissa Emika Massuda, Vanessa Silva Gontijo, and Claudio Viegas, Jr., “Monoamine Oxidase Inhibitors in Drug Discovery Against Parkinson’s Disease: An Update,” Pharmaceuticals, October 2025, https://www.mdpi.com/1424-8247/18/10/1526.
- S.A. Forman and K.W. Miller, “Procaine rapidly inactivates acetylcholine receptors from Torpedo and competes with agonist for inhibition sites,” Biochemistry, February 1989, https://pubmed.ncbi.nlm.nih.gov/2719927/.